Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 28, 2016; 22(48): 10592-10600
Published online Dec 28, 2016. doi: 10.3748/wjg.v22.i48.10592
Published online Dec 28, 2016. doi: 10.3748/wjg.v22.i48.10592
Table 1 Annual incidence of adenocarcinoma and dysplasia dependent on year of surveillance
| Calendar years | Total patient-years follow-up | Adenocarcinoma | High-grade dysplasia and adenocarcinoma | All grades of dysplasia and adenocarcinoma | |||
| Number of cases | Annual incidence | Number of cases | Annual incidence | Number of cases | Annual incidence | ||
| 1974-1989 | 237 | 0 | 0.00% | 0 | 0.00% | 1 | 0.46% |
| 1990-1994 | 753 | 1 | 0.13% | 1 | 0.13% | 9 | 1.33% |
| 1995-1999 | 1950 | 19 | 0.97% | 21 | 1.09% | 76 | 4.70% |
| 2000-2004 | 2058 | 15 | 0.73% | 23 | 1.12% | 60 | 3.63% |
| 2005- | 1477 | 19 | 1.29% | 25 | 1.17% | 44 | 3.66% |
| Total | 6474 | 54 | 0.83% | 70 | 1.09% | 190 | 3.54% |
- Citation: Gatenby P, Bhattacharjee S, Wall C, Caygill C, Watson A. Risk stratification for malignant progression in Barrett’s esophagus: Gender, age, duration and year of surveillance. World J Gastroenterol 2016; 22(48): 10592-10600
- URL: https://www.wjgnet.com/1007-9327/full/v22/i48/10592.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i48.10592